Cellebrite DI (NASDAQ:CLBT) Shares Gap Up After Analyst Upgrade

Cellebrite DI Ltd. (NASDAQ:CLBT)’s stock price gapped up before the market opened on Thursday after Needham & Company LLC raised their price target on the stock from $22.00 to $24.00. The stock had previously closed at $15.97, but opened at $18.80. Needham & Company LLC currently has a buy rating on the stock. Cellebrite DI shares last traded at $19.91, with a volume of 913,167 shares trading hands.

Several other analysts also recently weighed in on CLBT. JPMorgan Chase & Co. boosted their price objective on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 24th. Lake Street Capital decreased their price target on shares of Cellebrite DI from $24.00 to $22.00 and set a “buy” rating for the company in a research report on Friday, August 15th. Weiss Ratings raised shares of Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, November 7th. Finally, Wall Street Zen cut Cellebrite DI from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $23.00.

Institutional Investors Weigh In On Cellebrite DI

Several hedge funds have recently added to or reduced their stakes in the company. Vestcor Inc bought a new stake in shares of Cellebrite DI in the 3rd quarter worth approximately $70,000. Swiss National Bank lifted its holdings in shares of Cellebrite DI by 1.4% in the 3rd quarter. Swiss National Bank now owns 210,100 shares of the company’s stock valued at $3,893,000 after acquiring an additional 3,000 shares during the last quarter. Blair William & Co. IL raised its position in Cellebrite DI by 3.9% in the 3rd quarter. Blair William & Co. IL now owns 89,425 shares of the company’s stock worth $1,657,000 after purchasing an additional 3,398 shares during the period. First Trust Advisors LP lifted its position in shares of Cellebrite DI by 227.1% in the 3rd quarter. First Trust Advisors LP now owns 69,653 shares of the company’s stock worth $1,291,000 after purchasing an additional 48,360 shares during the period. Finally, Norwood Investment Partners LP acquired a new position in shares of Cellebrite DI in the third quarter worth about $4,274,000. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Trading Up 24.7%

The firm’s 50-day moving average is $17.72 and its two-hundred day moving average is $16.69. The stock has a market cap of $4.77 billion, a price-to-earnings ratio of -26.19, a P/E/G ratio of 3.16 and a beta of 1.28.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.05). The company had revenue of $126.03 million for the quarter, compared to analyst estimates of $122.98 million. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.The firm’s revenue for the quarter was up 17.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.14 EPS. Cellebrite DI has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, analysts predict that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.